ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 829,51
0,06%
DAX
18 726,76
-0,21%
Brent Oil
82,905
-0,75%
Bitcoin
69 701,59
-2,45%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Codiak BioSciences Inc (CDAK)

  7. Codiak BioSciences Inc (CDAK) Actualités

CDAK

Codiak BioSciences (CDAK)

Codiak BioSciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CDAK
DateHeureSourceTitreSymboleSociété
31/03/202300h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDAKCodiak BioSciences Inc
29/03/202312h05Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:CDAKCodiak BioSciences Inc
29/03/202312h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDAKCodiak BioSciences Inc
27/03/202313h00GlobeNewswire Inc.Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 ProcessNASDAQ:CDAKCodiak BioSciences Inc
03/03/202322h03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CDAKCodiak BioSciences Inc
14/02/202318h19Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CDAKCodiak BioSciences Inc
28/11/202219h00GlobeNewswire Inc.Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx ConferenceNASDAQ:CDAKCodiak BioSciences Inc
10/11/202215h00GlobeNewswire Inc.Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual MeetingNASDAQ:CDAKCodiak BioSciences Inc
03/11/202221h01GlobeNewswire Inc.Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational ProgressNASDAQ:CDAKCodiak BioSciences Inc
12/10/202214h00GlobeNewswire Inc.Codiak Presents Preclinical Data Demonstrating its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of SARS-CoV-2 and Related SarbecovirusesNASDAQ:CDAKCodiak BioSciences Inc
05/10/202214h00GlobeNewswire Inc.Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting MacrophagesNASDAQ:CDAKCodiak BioSciences Inc
20/09/202222h58Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CDAKCodiak BioSciences Inc
14/09/202212h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CDAKCodiak BioSciences Inc
13/09/202211h34TipRanksCodiak BioSciences (NASDAQ: CDAK) Drops Following Planned Public OfferingNASDAQ:CDAKCodiak BioSciences Inc
13/09/202203h05GlobeNewswire Inc.Codiak Announces Pricing of $20 Million Public Offering of Common Stock and WarrantsNASDAQ:CDAKCodiak BioSciences Inc
12/09/202222h01GlobeNewswire Inc.Codiak Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:CDAKCodiak BioSciences Inc
30/08/202215h10GlobeNewswire Inc.Codiak BioSciences Announces Program Reprioritization and Corporate RestructuringNASDAQ:CDAKCodiak BioSciences Inc
04/08/202222h17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDAKCodiak BioSciences Inc
04/08/202222h01GlobeNewswire Inc.Codiak BioSciences Reports Second Quarter 2022 Financial Results and Operational ProgressNASDAQ:CDAKCodiak BioSciences Inc
03/08/202222h15GlobeNewswire Inc.Codiak BioSciences to Participate in Upcoming BTIG and Wedbush PacGrow Investor ConferencesNASDAQ:CDAKCodiak BioSciences Inc
11/07/202215h44GlobeNewswire Inc.Codiak BioSciences to Participate at William Blair Biotech Focus Conference 2022NASDAQ:CDAKCodiak BioSciences Inc
05/07/202214h33TipRanksGoldman Sachs Thinks Codiak BioSciences’ Stock is Going to RecoverNASDAQ:CDAKCodiak BioSciences Inc
05/07/202212h30GlobeNewswire Inc.CEPI and Codiak BioSciences partner to develop broadly protective Betacoronavirus vaccineNASDAQ:CDAKCodiak BioSciences Inc
02/07/202215h15TipRanksCodiak BioSciences (CDAK) Gets a Buy Rating from William BlairNASDAQ:CDAKCodiak BioSciences Inc
30/06/202212h30GlobeNewswire Inc.Codiak Provides Platform-Validating Clinical Update and Data from Phase 1 Trials of exoSTING™ and exoIL-12™NASDAQ:CDAKCodiak BioSciences Inc
29/06/202214h00GlobeNewswire Inc.Codiak Initiates Patient Dosing in Phase 1 Clinical Trial of exoASO™-STAT6 in Patients with Advanced Hepatocellular Carcinoma, Liver Metastases from Primary Gastric Cancer and Colorectal CancerNASDAQ:CDAKCodiak BioSciences Inc
17/05/202213h00GlobeNewswire Inc.Codiak Presents New Preclinical Data at ASGCT 2022 on Exosome-Based Strategy to Enhance AAV Gene TherapyNASDAQ:CDAKCodiak BioSciences Inc
05/05/202222h01GlobeNewswire Inc.Codiak BioSciences Reports First Quarter 2022 Financial Results and Operational ProgressNASDAQ:CDAKCodiak BioSciences Inc
04/05/202222h27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CDAKCodiak BioSciences Inc
02/05/202215h00GlobeNewswire Inc.Codiak Appoints David Mauro, M.D., Ph.D., as Chief Medical OfficerNASDAQ:CDAKCodiak BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:CDAK

Dernières Valeurs Consultées

NASDAQ
NVDA
NVIDIA
EU
ACA
Credit Agricole
EU
BN
Danone
FTSE
UKX
FTSE 100
EU
ORA
Orange
EU
PX4
SBF 120
NYSE
MRK
Merck
EU
AI
Air Liquide
EU
ML
Michelin
NYSE
NKE
Nike
EU
RI
Pernod Ricard
EU
CS
Axa
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés